1. Paradoxical bronchoconstriction with nebuliser use

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. Meningitis development during cephalosporin therapy

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. Complications associated with phenylpropanolamine-containing OTC preparations

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. In defence of clomifene

   Newsletter Article 12 February 2013 Pages: 3 - 3

5. Drug interactions influencing hypertension control

   Newsletter Article 12 February 2013 Pages: 3 - 4

6. Allopurinol

   Newsletter Article 12 February 2013 Pages: 4 - 4

7. Amiodarone

   Newsletter Article 12 February 2013 Pages: 4 - 5

8. Amiodarone interaction

   Newsletter Article 12 February 2013 Pages: 5 - 5

9. Anticonvulsants see Corticosteroids interaction

   Newsletter Article 12 February 2013 Pages: 5 - 5

10. Anti-inflammatories, non-steroidal

    Newsletter Article 12 February 2013 Pages: 5 - 5

11. Antipsychotics

    Newsletter Article 12 February 2013 Pages: 5 - 5

12. Antithyroids

    Newsletter Article 12 February 2013 Pages: 5 - 5

13. Antituberculars

    Newsletter Article 12 February 2013 Pages: 5 - 5

14. Aspirin

    Newsletter Article 12 February 2013 Pages: 5 - 5

15. Buspirone

    Newsletter Article 12 February 2013 Pages: 5 - 6

16. Captopril

    Newsletter Article 12 February 2013 Pages: 6 - 6

17. Calcium hopantenate

    Newsletter Article 12 February 2013 Pages: 6 - 6

18. Cefazolin

    Newsletter Article 12 February 2013 Pages: 6 - 6

19. Ceftriaxone

    Newsletter Article 12 February 2013 Pages: 6 - 7

20. Charcoal/sorbitol

    Newsletter Article 12 February 2013 Pages: 7 - 7

21. Cimetidine

    Newsletter Article 12 February 2013 Pages: 7 - 7

22. Cimetidine see Ranitidine/cimetidine

    Newsletter Article 12 February 2013 Pages: 7 - 7

23. Cisplatin

    Newsletter Article 12 February 2013 Pages: 7 - 7

24. Clorazepate

    Newsletter Article 12 February 2013 Pages: 7 - 7

25. Cocaine abuse

    Newsletter Article 12 February 2013 Pages: 7 - 7

26. Contraceptives, oral

    Newsletter Article 12 February 2013 Pages: 7 - 7

27. Corticosteroids interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

28. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 7 - 8

29. Cyclosporin interactions

    Newsletter Article 12 February 2013 Pages: 8 - 8

30. Cyclosporin withdrawal

    Newsletter Article 12 February 2013 Pages: 8 - 8

31. Cyproheptadine

    Newsletter Article 12 February 2013 Pages: 8 - 8

32. Dacarbazine

    Newsletter Article 12 February 2013 Pages: 8 - 8

33. Fluvoxamine overdose

    Newsletter Article 12 February 2013 Pages: 8 - 9

34. Halothane see Suxamethonium

    Newsletter Article 12 February 2013 Pages: 9 - 9

35. Ibuprofen

    Newsletter Article 12 February 2013 Pages: 9 - 9

36. Ifosfamide

    Newsletter Article 12 February 2013 Pages: 9 - 9

37. Imipramine

    Newsletter Article 12 February 2013 Pages: 9 - 9

38. Ketoconazole

    Newsletter Article 12 February 2013 Pages: 9 - 9

39. Lithium overdose

    Newsletter Article 12 February 2013 Pages: 9 - 9

40. Lovastatin

    Newsletter Article 12 February 2013 Pages: 9 - 9

41. Medroxyprogesterone

    Newsletter Article 12 February 2013 Pages: 9 - 9

42. Methazolamide

    Newsletter Article 12 February 2013 Pages: 10 - 10

43. Methotrexate interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

44. Metoprolol see Amiodarone interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

45. Mexiletine

    Newsletter Article 12 February 2013 Pages: 10 - 10

46. Nalidixic acid interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

47. Octreotide dependence

    Newsletter Article 12 February 2013 Pages: 10 - 10

48. Paracetamol

    Newsletter Article 12 February 2013 Pages: 10 - 10

49. Peplomycin

    Newsletter Article 12 February 2013 Pages: 10 - 10

50. Phenytoin

    Newsletter Article 12 February 2013 Pages: 10 - 10